
Cypherpunk secures a $46M Zcash gain and turns a $4.7M operating loss into $39.4M profit
Zcash treasury firm and Leap Therapeutics owner, Cypherpunk Technologies, reported $39.4 million in second-quarter net income, reversing a $16.6 million loss a year earlier. Cypherpunk recorded a $4.7 million operating...
Bitcoin 1 Minute
A notable development has hit the crypto markets. Zcash treasury firm and Leap Therapeutics owner, Cypherpunk Technologies, reported $39. 4 million in second-quarter net income, reversing a $16. 6 million loss a year earlier.
Cypherpunk recorded a $4. 7 million operating loss, while a $46 million unrealized gain on its ZEC treasury drove the change in its bottom line. Research and development expense accounted for $0.
Market Dynamics
2 million of the quarter’s costs, while general and administrative expense was $4. That left the company loss-making at the operating level before the ZEC revaluation was reflected in the income statement. The accounting treatment recognizes price movements without requiring Cypherpunk to sell the tokens.
Related Reading BitMine made $46 million staking Ethereum then lost twice that betting on it Staking generated nearly all quarterly revenue as the company issued billions of dollars in stock to finance a treasury sitting $8. 2 billion below cost. Jul 15, 2026 Oluwapelumi Adejumo The $46 million gain was a period-end accounting result, and Cypherpunk marks its Zcash holdings to market at each reporting date.
It used a ZEC price of $400. 09 at June 30, valuing the treasury at $129. 4 million on its balance sheet.
Market Impact
Cypherpunk reported $39. 4 million in Q2 net income as a $46 million unrealized ZEC gain offset a $4. 7 million operating loss.
Cypherpunk said it held 323,394. 11 at an average purchase price of $341. 83, which is approximately 1.
92% of the circulating supply. That average implies an aggregate acquisition cost of roughly $110. 34 on CoinGecko at 11:27 UTC on Aug.
This shift continues to shape the digital-asset landscape, with analysts examining its near-term effects.




